Indometacin Farnesil 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±1.8 mmHg at 25℃ |
| Water Solubility | Insoluble |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.547 |
| B pt. | 626.6℃ at 760 mmHg |
| M pt. | 333℃ |
| Density | 1.08g/cm3 |
Safety Information
| Hazard Statement(s) | H302 |
| Precautionary Statement | P501-P270-P264-P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 332.7℃ |
| Storage Temp. | Store at room temperature.. |
| Packaging | Glass Bottle |
Description
Recommended products
Sudan Iv
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Indometacin farnesil (INN) is a prodrug of the non-steroidal anti-inflammatory drug indometacin designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indometacin with farnesol. Indometacin farnesil was first approved in Japan in 1991 and is available in Japan and Indonesia under the trade names Infree and Dialon respectively.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |